José Antonio García Erce Highlights the Updating of the Criteria for the Donation of Plasmapheresis for Industrial Fractionation
José Antonio García Erce, Director of the Donation Center, Navarre Health Service (Osasunbidea), posted on LinkedIn:
“NEW CAT 2025 STANDARDS VERSION
As of YESTERDAY, December 19, the 6th edition of the CAT Standards in Hemotherapy 2025 comes into force. From now on, transfusion centres and services will have a period of three months to adopt the changes.
We must congratulate and thank all the professionals involved in the new version. There are interesting new developments.
I would like to highlight the updating of the criteria for the donation of plasmapheresis for industrial fractionation. It can be of great help to Transfusion Centers.
But I want to highlight a point that was already in the previous edition and that should also be applicable to transfusion centers, to Primary Care, as well as to all hospitals where transfusions are made:
4.2.7. TS must promote and participate in hospital Patient Blood Management (PBM) programs, including specific training.
Unfortunately, its definition included in the document, sorry, is not correct: “Patient Blood Management: a comprehensive and multidisciplinary strategy focused primarily on minimizing the use of allogeneic blood components, optimizing patient care by treating anemia, minimizing blood loss and bleeding, and improving their physiological reserve of red blood cells.” It does not focus on minimizing use, but on clinical improvement and patient safety, and preserving, promoting, and protecting the blood health of the entire population.”
Title: Patient blood management: haematology faces an urgent challenge in personalised medicine | Gestión de la sangre del paciente: la hematología ante un reto inaplazable en la medicina personalizada (original)
Authors: José Antonio García Erce
Read full paper here or have printable variant.
Read more from José Antonio García Erce on Hemostasis Today.
-
Jul 17, 2026, 04:28Redefining Thromboprophylaxis in Multiple Myeloma: Early VTE Emerges as the Critical Therapeutic Challenge
-
Jul 16, 2026, 20:25Ilham Benzidia: Leaving ISTH 2026 With New Ideas and New Collaborations
-
Jul 16, 2026, 20:23Eman Hassan: A Fantastic Platelets and Megakaryocytes Session at ISTH 2026
-
Jul 16, 2026, 20:22Sankara Nelson Noah II: Investigating the Temporal Dynamics of Platelet – Leukocyte Interactions in Early Sepsis
-
Jul 16, 2026, 20:20Joseph Pierre Aboumsallem: Paris Certainly Delivered This Week, and Not Just Because of the Heat
-
Jul 16, 2026, 19:53Louise St. Germain Bannon: The End of Congress, the Beginning of New Collaborations
-
Jul 16, 2026, 19:18Steve Humphreys: Learning From the Leading Experts at ISTH 2026
-
Jul 16, 2026, 19:02Kellie Machlus: Where Science Meets Friendship at ISTH 2026
-
Jul 16, 2026, 18:51Aaron Paul Kithcart: When Clinical Research Comes Together at ISTH 2026